 OraSure Technologies Inc NASDAQ: OSUR expects Q4 FY21 revenue at the low end of the Companys guidance range of approximately 60 million. The Company anticipates total InteliSwab revenue of approximately 12 million for Q4 and 20 million for FY21. 